Write what you believe about your stocks; every morning the cited record grades it: supported, challenged, or untouched. Never opinions.

Development · 22 Oct 2026

Paras Healthcare's Rs 1,450 crore IPO opened for subscription on October 21 and closes on October 23, with a grey market premium (GMP) of around 7%.

5 publishers have reported this development. Each act of reporting is below, cited.

The record

Paras Healthcare's Rs 1,450 crore IPO opened for subscription on October 21 and closes on October 23, with a grey market premium (GMP) of around 7%.

indiatimes.com21 Oct 2026

Paras Healthcare IPO opened on October 21, 2026.

zeebiz.com20 Oct 2026

Paras Healthcare IPO opens today.

businesstoday.in21 Oct 2026

Paras Healthcare has fixed the IPO price band at Rs 660-693 per share for its Rs 1,450 crore issue, which opens on October 21.

indiatimes.com19 Oct 2026

Paras Healthcare has fixed a price band of 660-693 per equity share for its initial public offering (IPO), which will be open for subscription from October 21-23.

indiatimes.com18 Oct 2026

Paras Healthcare has set its IPO price band at Rs 660-693 per share, targeting Rs 1,450 crore, opening October 21.

indiatimes.com16 Oct 2026

Paras Healthcare Ltd will launch its ₹1,450-crore initial public offering (IPO) on October 21, with a price band of ₹660-693 per share.

Paras Healthcare has fixed the price band for its IPO at ₹660–₹693 per share, with the issue opening on October 21 and closing on October 23.

fortuneindia.com15 Oct 2026

Every claim carries its citation

This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.

New here? The reader's guide explains every page, plate by plate.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.